Medicalgorithmics signs first commercial agreement for VCAST – AI-powered coronary CT analysis platform – marking entry into strategic scandinavian market
Warsaw Stock Exchange-listed Medicalgorithmics has signed a commercial agreement with NexGen MediQ, a distributor of advanced medical technologies in Sweden and the broader Scandinavian region. Under the agreement, the company’s breakthrough AI-based cardiac imaging solution, VCAST – positioned as a competitive alternative to U.S.-based solutions such as HeartFlow and Cleerly – will be made available to customers in the Scandinavian market following integration.